Publications by authors named "Kristian A Fuglsang"

Background And Aims: Despite advances in the medical treatment of Crohn's disease [CD], many patients will still need bowel resections and face the subsequent risk of recurrence and re-resection. We describe contemporary re-resection rates and identify disease-modifying factors and risk factors for re-resection.

Methods: We conducted a retrospective, population-based, individual patient-level data cohort study covering 47.

View Article and Find Full Text PDF

Background: Survival has frequently been studied and reported in patients with long term intestinal failure (IF). However, studies comparing the survival and mortality rates with the background population are rare. This study compares the survival in an adult IF, non-malignant, short bowel syndrome (SBS) cohort with a control group and with age- and sex-specific background mortality rates.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with short bowel syndrome (SBS) have trouble absorbing food and need special care, often getting nutrients through a tube instead of eating normally.
  • The study looked at 74 adults with SBS who were getting this special care in Denmark and found that they took an average of eight different medications.
  • Most of the medications were taken by mouth, and only a few needed to be given in higher amounts than usual to work properly.
View Article and Find Full Text PDF

Background: Progressive renal impairment, given by an annual decline in estimated glomerular filtration rate (eGFR), has been described in patients with intestinal failure (IF) receiving home parenteral support (HPS). The objective of this study was to examine changes in eGFR over 5 years following initiation of HPS treatment and to identify potential risk factors for loss of renal function.

Method: This retrospective database study investigates eGFR changes in nonmalignant IF patients discharged with HPS from Rigshospitalet, Copenhagen, in an 8-year period.

View Article and Find Full Text PDF

is a Gram-positive coccus and a commensal bacterium of the human gastrointestinal tract with a potential to cause invasive infections. We report the presence of in the blood of a 25-year-old male patient with Crohn's disease, short bowel syndrome treated with home parenteral nutrition, and a history of recurrent bloodstream infections, admitted to our hospital with fever and malaise. A polymicrobial culture of and was identified from blood, for which treatment with meropenem and metronidazole was initiated.

View Article and Find Full Text PDF

Background: Aim was to investigate the association between quality of life (QoL), bowel anatomy, and the need for home parenteral support (HPS) volume in patients with nonmalignant short-bowel syndrome (SBS) and intestinal failure (IF).

Methods: The SBS-QoL scale was used in a cross-sectional study of 95 nonmalignant SBS-IF patients. Sum QoL scores (0: best, 170: worst) were calculated.

View Article and Find Full Text PDF

Background: The objective of this retrospective cohort study was to assess the frequency, duration, and causes of hospitalizations in patients receiving home parenteral support (HPS) due to short-bowel syndrome (SBS) of nonmalignant causes. Furthermore, we aimed to investigate potential risk factors and hypothesized that patients with the shortest remnant, functional, small bowel-hence, the highest need for HPS-would have the highest incidence of hospitalizations.

Methods: Patients with nonmalignant SBS who initiated HPS in the period from 1970 to 2016 from the Department of Gastroenterology, Rigshospitalet, Copenhagen, Denmark, were included.

View Article and Find Full Text PDF
Article Synopsis
  • The study looked at how different ways of analyzing data can change the results about how patients with intestinal failure do when they get home care.
  • Researchers found that using different methods gave different results, especially in how many patients survive or are dependent on treatment.
  • They concluded that it's really important to use the right methods when studying these patients, so we can understand their outcomes better.
View Article and Find Full Text PDF

Background: Weaning from parenteral support is considered indirect evidence of intestinal adaptation in patients with short bowel syndrome (SBS), but direct evidence is lacking. The objective of this study was to examine if intestinal adaptation could be demonstrated as increase in intestinal absorption of energy and wet weight over time measured by repeated metabolic balance studies (MBSs) and to examine whether adaptation was determined by the anatomy of the remnant bowel.

Methods: We retrospectively analyzed data from 48 repeated MBSs performed in 13 adult patients with SBS.

View Article and Find Full Text PDF

Background: In intestinal failure (IF) patients receiving home parenteral support (HPS), catheter-related bloodstream infections (CRBSIs) frequently result in replacement of their tunneled central venous catheters (CVCs), which may lead to future loss of central venous access.

Objective: This observational study investigated the consequences of a catheter-salvage strategy related to CRBSIs.

Design: All CRBSIs from 2002 to 2016 in the Copenhagen IF and microbiological databases were retrospectively analyzed.

View Article and Find Full Text PDF

Intestinal failure (IF) is the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that parenteral support (PS) is required to maintain health and/or growth. This article critically revises the gaps in and evidence for providing general nutritional therapy recommendations in the Short Bowel Syndrome-IF population. It addresses the need for an individualized approach, aiming to reduce or even eliminate the need for PS, and emphasizes a need to focus on effects of dietary interventions on the quality of life of these patients.

View Article and Find Full Text PDF
Article Synopsis
  • A study explored the effectiveness of a new antimicrobial catheter lock solution, taurolidine-citrate-heparin, in reducing catheter-related bloodstream infections (CRBSIs) compared to traditional heparin in patients relying on home parenteral support (HPS) for intestinal failure.
  • In a double-blinded, placebo-controlled trial with 41 high-risk patients, no CRBSIs occurred in the taurolidine-citrate-heparin group, while there were 7 infections in the heparin group.
  • The taurolidine-citrate-heparin treatment not only led to fewer infections but also resulted in significantly lower treatment costs per year, contributing to increased catheter survival and reduced hospital admissions.
View Article and Find Full Text PDF